Skip to content

Transcranial Electrical Stimulation for Mal de Debarquement Syndrome

Transcranial Electrical Stimulation for Mal de Debarquement Syndrome

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02540616
Enrollment
0
Registered
2015-09-04
Start date
2013-09-30
Completion date
2022-12-31
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mal de Debarquement Syndrome

Keywords

MdDS, TES, TMS

Brief summary

The goal of this study is to determine whether external neuromodulation using transcranial electrical stimulation (TES) can reduce the perception of self-motion that is experienced by patients with MdDS. Mal de debarquement is translated as the sickness of disembarkment, and refers to the chronic feeling of rocking dizziness that occurs after exposure to passive motion. A similar form of rocking dizziness can be experienced without a motion trigger in individuals with certain risk factors. Treatment for MdDS is limited and morbidity is high.The goal of the study is to determine whether TES can suppress the rocking dizziness of MdDS either as a standalone therapy or as an adjunctive therapy to other forms of neuromodulation such as transcranial magnetic stimulation. The investigators will determine the optimal treatment duration and stimulation parameters.

Detailed description

Eligible participants who meet study criteria and pass the safety screen will be invited to participate in the study. If TES is used as add-on treatment to repetitive transcranial magnetic stimulation (rTMS), the training for TES application will be done on-site. However, in a portion of the study that does not involve rTMS, remote training will be performed via a webcam provided that a suitable Study Buddy is available to assist the participant. Participants will maintain web-based diaries of their symptoms for up to four weeks prior to treatment with TES. Before the actual treatment sessions are started, the subjects will complete baseline questionnaires online which will be repeated once a week for up to 12 weeks. Over the course of the study, the subjects will also keep a daily log of their sessions such as how many sessions they performed, for how long, and whether they had any side effects with each session. The studies will include a sham arm, allocated at a ratio of 1:1. On-site studies will involve the application of EEG, MRI, balance, cognitive, and visual/auditory stimulation tests.

Interventions

DEVICETranscranial Electrical Stimulation

A form of external neuromodulation using electrodes on the surface of the head. We will be using the TCT tDCS device (www.trans.cranial.com) or devices constructed by our research group or collaborators.

Sponsors

University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

Participants will be randomized to a real vs a sham stimulation arm. The sham arm will be offered real treatment after unblinding.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥18 years old 2. Willing and capable of interacting with the informed consent process 3. Primary disorder being a persistent perception of motion with no other cause determined after a careful interview. 4. Able to identity a study buddy and provide contact information

Exclusion criteria

1. Subjects who cannot comply with study conditions. 2. Active psychiatric condition such as mania or psychosis 3. Unstable medical condition 4. Implanted metal in the head or neck (metal or shrapnel, deep brain stimulators, aneurysm clips, cochlear stimulators, retinal implants, etc). Dental fillings are acceptable. 5. Any active skin disorder that affects skin integrity of the scalp. 6. Pregnant

Design outcomes

Primary

MeasureTime frameDescription
Dizziness Handicap Inventory10 yearsThis is a well validated 100 point self-reported scale with Functional, Physical, and Emotional components.

Secondary

MeasureTime frameDescription
Mal de Debarquement Balance Rating Scale10 yearsThis is a 10 point self-reported scale that assesses the severity of rocking dizziness and its effect on balance function.
Hospital Anxiety and Depression Scale10 yearsThis is a well validated 42 point self-reported scale of anxiety and dizziness.

Other

MeasureTime frameDescription
Neo-Five Factor Inventory10 yearsQuantifies the five major personality traits
Empathy Quotient10 years40 item online or 20 item abbreviated scale to determine strength of empathic traits
Edinburgh Handedness Scale10 yearsStandard measure of handedness
Memory Questionnaire10 yearsMeasures subjective impressions of prospective and retrospective memory
Multidimensional Fatigue Inventory10 yearsMeasures general, physical, and mental fatigue
Functional Activities Scale10 yearsMeasures comfort with doing some basic activities of daily living
SF-1210 yearsWell established Quality of Life Scale
Motion Sickness Susceptibility Scale10 yearsMeasures motion sickness susceptibility before and after age 12

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026